ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,932.30
-0.18%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.555
0.10%
Brent Oil
84.285
0.40%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/1015 : 15PR Newswire (US)Novavax Reports First Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
2024/05/1015 : 15PR Newswire (US)Sanad Announces Strategic Sale Transaction with CFM Materials, Further Fostering Aviation Industry Collaborations
2024/05/1015 : 09GlobeNewswire Inc.INDICATEURS TRIMESTRIELS DE CMT AU 31 MARS 2024 • Chiffre d’affaires en progression et poursuite de la baisse de l’endettementEU:ALAMGAuplata Mining Group
2024/05/1015 : 05Business WireCRH Continues Share Buyback ProgramNYSE:CRHCRH Plc
2024/05/1015 : 00Alliance NewsAlliance NewsIN BRIEF: Genedrive aims to raise at least GBP6 million in share offerLSE:GDRGenedrive Plc
2024/05/1015 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19BIT:SANFSanofi
2024/05/1015 : 00GlobeNewswire Inc.Record de volume traité 137 KtEU:ALAMGAuplata Mining Group
2024/05/1015 : 00GlobeNewswire Inc.Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
2024/05/1015 : 00GlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesBIT:1SANSanofi
2024/05/1015 : 00Business WireShionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
2024/05/1015 : 00GlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesTG:SNWSanofi
2024/05/1015 : 00GlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesBIT:SANFSanofi
2024/05/1015 : 00GlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesEU:SANSanofi
2024/05/1015 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19EU:SANSanofi
2024/05/1015 : 00GlobeNewswire Inc.PGS Contract Award in West AfricaTG:PGS1PGS ASA
2024/05/1015 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19BIT:1SANSanofi
2024/05/1015 : 00GlobeNewswire Inc.Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesEU:SANSanofi
2024/05/1015 : 00GlobeNewswire Inc.Communiqué de presse : Sanofi et Novavax concluent un accord de licence co-exclusif pour la co-commercialisation d’un vaccin COVID-19 et le développement de vaccins combinés grippe - COVID-19TG:SNWSanofi
2024/05/1015 : 00Business WireCRH Q1 2024 ResultsNYSE:CRHCRH Plc
2024/05/1015 : 00PR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:NVAXNovavax Inc
2024/05/1015 : 00PR Newswire (US)Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesNASDAQ:SNYSanofi
2024/05/1014 : 55Alliance NewsAlliance NewsLONDON MARKET EARLY CALL: FTSE 100 called up on BoE hold, pre-UK GDP
2024/05/1014 : 41CointelegraphRNDR pumps 11% after Apple mentions OctaneCOIN:BTCUSDBitcoin
2024/05/1014 : 39CointelegraphPresident Joe Biden is trying hard to 'kill crypto', says Cardano founderCOIN:ADAUSDCardano
2024/05/1014 : 37Alliance NewsAlliance NewsGET READY: CRH, IAG, Rightmove, TBC Bank at 0700 BSTLSE:CRHCrh Plc
2024/05/1014 : 37Alliance NewsAlliance NewsGET READY: CRH, IAG, Rightmove, TBC Bank at 0700 BSTLSE:CRHCrh Plc
2024/05/1014 : 36Alliance NewsAlliance NewsAlliance News UK - start of day
2024/05/1014 : 30GlobeNewswire Inc.VIEL & Cie : 1er trimestre 2024 : Croissance du chiffre d’affaires de 5,2% à 299,0 millions d’eurosEU:VILViel et Compagnie
2024/05/1014 : 30GlobeNewswire Inc.Transaction in Own SharesTG:6E2Endeavour Mining Corp
2024/05/1014 : 30GlobeNewswire Inc.Iveco Group 2024 First Quarter ResultsBIT:IVGIveco Group NV

最近閲覧した銘柄

AMEX
SPY
SPDR S&P 500
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
NKE
Nike
PM
XAUUSD
Gold vs US Dollar
USOTC
BASFY
BASF (QX)
USI
USTECH100
US Tech 100
CCOM
US30
US 30
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
NYSE
AXP
American Express
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有